Manchester Capital Management’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-35
Closed -$1.52K – 1090
2023
Q1
$1.52K Buy
35
+9
+35% +$397 ﹤0.01% 846
2022
Q4
$970 Buy
26
+22
+550% +$851 ﹤0.01% 822
2022
Q3
$0 Sell
4
-13
-76% -$481 ﹤0.01% 970
2022
Q2
$1K Buy
+17
New +$615 ﹤0.01% 858

Other funds holding NRC

Manchester Capital Management's NRC Position: Q2 2023 in Review

Manchester Capital Management sold out of NRC Health Common Stock (NRC) in Q2 2023, closing a stake of 35 shares — an estimated $1.52K sold.

Manchester Capital Management first reported a position in NRC in Q2 2022 and held it in 4 quarters. The position peaked at $1.52K in Q1 2023. 116 funds tracked by Wall St. Rank hold NRC as of Q2 2023.

  • Manchester Capital Management reported no remaining NRC Health Common Stock position as of Q2 2023 after selling out during the quarter.
  • Manchester Capital Management sold 35 NRC Health Common Stock shares in Q2 2023, an estimated $1.52K.
  • Manchester Capital Management first reported a position in NRC Health Common Stock in Q2 2022 and held it in 4 quarters.
  • Manchester Capital Management's NRC Health Common Stock position peaked at $1.52K in Q1 2023.
  • 116 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2023.

Based on Manchester Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.